Jim Simons Allarity Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.22 - $31640.0 $2,970 - $427 Million
13,500 Added 53.39%
38,786 $11,000
Q3 2022

Nov 14, 2022
SELL
$1.04 - $34160.0 $63,511 - $2.09 Billion
-61,069 Reduced 70.72%
25,286 $28,000
Q2 2022

Aug 12, 2022
SELL
$1.11 - $2.99 $30,937 - $83,337
-27,872 Reduced 24.4%
86,355 $114,000
Q1 2022

May 13, 2022
BUY
$1.93 - $10.75 $220,458 - $1.23 Million
114,227 New
114,227 $233,000

Others Institutions Holding ALLR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Allarity Therapeutics, Inc.

ALLR Quotes by TradingView
  • Ticker ALLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,260,200
  • Market Cap $35M
  • Description
  • Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...
More about ALLR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email